{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T21:14:41Z","timestamp":1783372481612,"version":"3.54.6"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s12094-011-0724-8","type":"journal-article","created":{"date-parts":[[2011,11,16]],"date-time":"2011-11-16T03:52:19Z","timestamp":1321415539000},"page":"731-736","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic significance of biochemical markers in African Burkitt\u2019s lymphoma"],"prefix":"10.1007","volume":"13","author":[{"given":"Fareed Kow Nanse","family":"Arthur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Owusu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis Agyemang","family":"Yeboah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Rettig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Osei-Akoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,16]]},"reference":[{"key":"724_CR1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0065-230X(08)60470-4","volume":"55","author":"I. Magrath","year":"1990","unstructured":"Magrath I (1990) The pathogenesis of Burkitt\u2019s lymphoma. Adv Cancer Res 55:133\u2013270","journal-title":"Adv Cancer Res"},{"key":"724_CR2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MOP.0b013e3280140613","volume":"19","author":"M. Ansari","year":"2007","unstructured":"Ansari M, Krajinovic M (2007) Pharmacogenomics in cancer treatment defining the genetic bases for inter-individual differences in response to chemotherapy. Curr Opin Pediatr 19:15\u201322","journal-title":"Curr Opin Pediatr"},{"key":"724_CR3","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"M.A. Shipp","year":"1993","unstructured":"Shipp MA (1993) for The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project: a predictive model for aggressive Non-Hodgkin\u2019s Lymphoma: The International Non-Hodgkin\u2019s Lymphoma Project. N Engl J Med 329:987\u2013994","journal-title":"N Engl J Med"},{"key":"724_CR4","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood.V86.4.1460.bloodjournal8641460","volume":"88","author":"J. Hermans","year":"1995","unstructured":"Hermans J, Krol ADG, van Groningen K et al (1995) International Prognostic Index is valid for all malignant grades. Blood 88:1460\u20131463","journal-title":"Blood"},{"key":"724_CR5","first-page":"783","volume":"95","author":"M. Federico","year":"2000","unstructured":"Federico M, Umberto V, Zinzani PL et al (2000) Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Blood 95:783\u2013789","journal-title":"Blood"},{"key":"724_CR6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000011886","volume":"55","author":"C. Nicolaides","year":"1998","unstructured":"Nicolaides C, Fountzilas G, Zoumbos N et al (1998) Diffuse large cell lymphomas: identification of prognostic factors and validation of the international Non-Hodgkin\u2019s Lymphoma Prognostic Index. Oncology 55:405\u2013415","journal-title":"Oncology"},{"key":"724_CR7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1634\/theoncologist.3-3-189","volume":"3","author":"C. Nocolaides","year":"1998","unstructured":"Nocolaides C, Dimon S, Pavlidis N (1998) Prognostic factors in aggressive non-Hodgkin\u2019s lymphomas. Oncologist 3:189\u2013197","journal-title":"Oncologist"},{"key":"724_CR8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1600-0609.2005.00564.x","volume":"76","author":"F. Plancarte","year":"2006","unstructured":"Plancarte F, L\u00f3pez-Guillermo A, Arenillas L et al (2006) Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients. Eur J Haematol 76:58\u201363","journal-title":"Eur J Haematol"},{"key":"724_CR9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2223\/JPED.1726","volume":"83","author":"M.F. Pedrosa","year":"2007","unstructured":"Pedrosa MF, Pedrosa F, Lins MM et al (2007) Non-Hodgkin\u2019s lymphoma in childhood: clinical and epidemiological characteristics and survival analysis at a single centre in Northeast Brazil. J Pediatr (Rio J) 83:547\u2013554","journal-title":"J Pediatr (Rio J)"},{"key":"724_CR10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/09674845.2010.11730283","volume":"67","author":"L. Owusu","year":"2010","unstructured":"Owusu L, Yeboah FA, Sei-Akoto A et al (2010) Clinical and epidemiological characterisation of Burkitt\u2019s lymphoma: an eight-year case study at Komfo Anokye Teaching Hospital, Ghana. Br J Biomed Sci 67:9\u201314","journal-title":"Br J Biomed Sci"},{"key":"724_CR11","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"B.D. Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B et al (1999) Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. J Clin Oncol 17:1244\u20131253","journal-title":"J Clin Oncol"},{"key":"724_CR12","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/bmj.328.7447.1073","volume":"328","author":"J.M. Bland","year":"2004","unstructured":"Bland JM, Altman DG (2004) The logrank test. BMJ 328:1073","journal-title":"BMJ"},{"key":"724_CR13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/archinte.138.3.413","volume":"138","author":"F. Cabanilla","year":"1978","unstructured":"Cabanilla F, Burke JS, Smith TL et al (1978) Factors predicting response and survival in adults with advanced non-Hodgkin\u2019s lymphoma. Arch Intern Med 138:413\u2013418","journal-title":"Arch Intern Med"},{"key":"724_CR14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/1097-0142(19800701)46:1<139::AID-CNCR2820460122>3.0.CO;2-8","volume":"46","author":"R.J. Schneider","year":"1980","unstructured":"Schneider RJ, Scibert K, Passe S et al (1980) Prognostic significance of serum lactate dehydrogenase in malignant lymphomas. Cancer 46:139\u2013143","journal-title":"Cancer"},{"key":"724_CR15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood.V58.1.45.45","volume":"58","author":"R.I. Fisher","year":"1981","unstructured":"Fisher RI, Hubbard SM, De Vita VT et al (1981) Factors predicting long-term survival in diffuse mixed, histiocytic or undifferentiated lymphoma. Blood 58:45\u201351","journal-title":"Blood"},{"key":"724_CR16","first-page":"211","volume":"9","author":"B. Coiffier","year":"1991","unstructured":"Coiffier B, Gisselbrecht C, Vose JM et al (1991) Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d\u2019Etudes des Lymphomas Aggresifs. J Clin Oncol 9:211\u2013219","journal-title":"The Groupe d\u2019Etudes des Lymphomas Aggresifs. J Clin Oncol"},{"key":"724_CR17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1200\/JCO.1991.9.2.220","volume":"9","author":"P.J. Hoskin","year":"1991","unstructured":"Hoskin PJ, Ng V, Spinelli JJ et al (1991) Prognostic variables in patients with diffuse large cell lymphoma treated with MACOP-B. J Clin Oncol 9:220\u2013226","journal-title":"J Clin Oncol"},{"key":"724_CR18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/oxfordjournals.annonc.a058044","volume":"2","author":"R.C. Leonard","year":"1991","unstructured":"Leonard RC, Hayward RL, Prescott RJ et al (1991) The identification of discrete prognosis groups in low-grade non-Hodgkin\u2019s lymphoma. Ann Oncol 2:655\u2013662","journal-title":"Ann Oncol"},{"key":"724_CR19","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.1994.12.7.1343","volume":"12","author":"A. Lopez-Guillermo","year":"1994","unstructured":"Lopez-Guillermo A, Montserrat E, Bosch F et al (1994) Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma. J Clin Oncol 12:1343\u20131348","journal-title":"J Clin Oncol"},{"key":"724_CR20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2249.1991.tb05803.x","volume":"86","author":"L. Pan","year":"1991","unstructured":"Pan L, Beverly PCL, Isaacson PG (1991) Lactate dehydrogenase (LDH) isoenzymes and proliferative activity of lymphoid cells: an immunocytochemical study. Clin Exp Immunol 86:240\u2013245","journal-title":"Clin Exp Immunol"},{"key":"724_CR21","first-page":"12","volume-title":"Clinical biochemistry","author":"A. Gaw","year":"1999","unstructured":"Gaw A, Cowan RA, O\u2019Reilly DStJ et al (1999) Clinical biochemistry, 2nd ed. Harcourt Brace and Company, Edinburgh, pp 12\u201344, 64\u201372","edition":"2nd ed"},{"key":"724_CR22","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1182\/blood.V77.5.942.942","volume":"77","author":"W.S. Velasquez","year":"1991","unstructured":"Velasquez WS, Fuller LM, Jaganuath S et al (1991) Stage I and II diffuse large cell lymphoma: prognostic factors and long-term results with CHOP-bleo and radiation. Blood 77:942\u2013947","journal-title":"Blood"},{"key":"724_CR23","first-page":"295","volume":"4","author":"D.O. Dixon","year":"1986","unstructured":"Dixon DO, Neilan B, Jones SE et al (1986) Effect of age on the therapeutic outcome in advanced diffused histiocytic lymphoma. The Southwest Oncology Group Experience. J Clin Oncol 4:295\u2013305","journal-title":"The Southwest Oncology Group Experience. J Clin Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-011-0724-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-011-0724-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-011-0724-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T14:36:13Z","timestamp":1593268573000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-011-0724-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["724"],"URL":"https:\/\/doi.org\/10.1007\/s12094-011-0724-8","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}